EUVIMEDEUVIMED entdecken
Crossref

Siderophore–Porphyrin conjugates for bacteria-selective antimicrobial photodynamic therapy

Jinyoung Oh, Seunghyun Choi, Woojin Yang, Jieun Choi, Jiwon Seo

Medicinal Chemistry Research · 2026

DOI: 10.1007/s00044-026-03537-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicinal Chemistry Research, 2026. Verfasst von Jinyoung Oh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju, 61005, Republic of Korea. Hauptthemen laut MEDLINE: Porphyrins, Siderophores, Photochemotherapy, Photosensitizing Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted delivery of photosensitizers represents a key strategy for improving the selectivity and efficacy of antimicrobial photodynamic therapy (aPDT). Herein, we describe the synthesis and biological evaluation of siderophore-conjugated photosensitizers designed to exploit bacterial iron acquisition pathways. Four distinct photosensitizers-neutral porphyrin (TPP), cationic porphyrin (TMPyP), metalloporphyrin (PdTMPyP), and chlorin (Ce6)-were covalently linked to deferoxamine B (DFO), a clinically approved hydroxamate siderophore. The resulting conjugates retained their intrinsic photophysical properties while exhibiting iron-dependent antimicrobial activity against siderophore-utilizing pathogens. TMPyP-DFO (3) was determined as the best compound, demonstrating potent antimicrobial photodynamic activity against Staphylococcus aureus and Acinetobacter baumannii under iron-deficient conditions (MIC50 = 6.3-12.5 µM) with low mammalian cytotoxicity (LC50 = 146.6 µM). Neutral porphyrin- and chlorin-siderophore conjugates (1 and 2, respectively) demonstrated either poor activity or lack of selectivity. These findings validate the 'Trojan horse' delivery strategy-achieved through the conjugation of cationic porphyrins with siderophores-as a promising strategy for enhancing bacterial selectivity in aPDT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PorphyrinsSiderophoresPhotochemotherapyPhotosensitizing AgentsStaphylococcus aureusAnti-Bacterial AgentsAcinetobacter baumanniiMicrobial Sensitivity TestsHumans

Stichwörter der Autor:innen

ChlorinPhotodynamic therapy (PDT)PhotosensitizerPorphyrinSiderophore

Substanzen

PorphyrinsSiderophoresPhotosensitizing AgentsAnti-Bacterial Agentschlorin

Autor:innen und Institutionen

  • Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju, 61005, Republic of Korea.
  • Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju, 61005, Republic of Korea. jseo@gist.ac.kr.

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Oh, J., Choi, S., Yang, W., Choi, J., & Seo, J. (2026). Siderophore–Porphyrin conjugates for bacteria-selective antimicrobial photodynamic therapy. Medicinal Chemistry Research. https://doi.org/10.1007/s00044-026-03537-2

Vancouver

Oh J, Choi S, Yang W, Choi J, Seo J. Siderophore–Porphyrin conjugates for bacteria-selective antimicrobial photodynamic therapy. Medicinal Chemistry Research. 2026. doi:10.1007/s00044-026-03537-2

BibTeX
@article{Oh2026,
  author = {Oh, Jinyoung and Choi, Seunghyun and Yang, Woojin and Choi, Jieun and Seo, Jiwon},
  title = {Siderophore–Porphyrin conjugates for bacteria-selective antimicrobial photodynamic therapy},
  journal = {Medicinal Chemistry Research},
  year = {2026},
  doi = {10.1007/s00044-026-03537-2}
}
Kostenlos starten →